MPCCC Precision Oncology Seminars illuminate ways to tackle rare and aggressive cancers

2019-10-21T13:55:12+00:00 October 21st, 2019|

The MPCCC Precision Oncology Program welcomed two eminent speakers in August and September 2019 to present at Precision Oncology Seminars. These seminars brought together researchers [...]

Dr Simon Wilkins recognised for innovative research into gastrointestinal cancers

2019-09-26T11:19:36+00:00 September 26th, 2019|

On 21-23 August 2019, The Australian Gastro-intestinal Trials Group (AGITG) held their Annual Scientific Meeting. Dr Simon Wilkins, a Senior Research Fellow at the Cabrini [...]

MPCCC’s Molecular Tumour Boards and Precision Oncology Seminars drive innovation in personalised cancer treatment

2019-07-08T11:15:58+00:00 July 8th, 2019|

Since its commencement in September 2018, the MPCCC Precision Oncology Program has established regular Molecular Tumour Board meetings that focus on three distinct tumour streams. [...]

MPCCC’s pilot of shared care for cancer-related depression reaches evaluation phase

2019-07-08T11:05:12+00:00 July 8th, 2019|

As MPCCC’s pilot of shared-care for cancer related depression approaches completion, participants will be invited to evaluate the feasibility of the model and its potential [...]

Landmark clinical trial delivers drastic improvement in survival for men with advanced prostate cancer

2019-06-27T14:44:46+00:00 June 27th, 2019|

Outcomes of the Australian-led landmark clinical trial, ENZAMET, are expected to influence clinical practice around the world for men with advanced metastatic prostate cancer. The [...]